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Objective: To examine the association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and hyperhomocystein-
emia in women with unexplained recurrent miscarriages (RM) and to investigate the association between MTHFR genotype variants and allo-
immune activation, proportion of peripheral blood natural killer (pbNK) cells.
Methods: A total of 39 patients with a history of two or more unexplained miscarriages were recruited to this study. The controls were women 
who had a live birth without a history of RM (n=50). The proportion of pbNK cells was measured by flow cytometry. Plasma homocysteine lev-
els and the incidence of the MTHFR variant of the RM and control groups were compared. The proportion of pbNK cells was compared to the 
MTHFR variants in the RM group.
Results: No differences were found between the two groups’ mean plasma homocysteine levels (7.6±1.5 μmol/L vs. 7.1±2.1 μmol/L) or inci-
dence of the MTHFR genotype variant (CC, 35% vs. 33%; CT, 40% vs. 53%; and TT, 25% vs. 14%). In the RM group, individuals with the TT variant 
(7.7±1.1 μmol/L) had higher homocysteine levels than those with the CC and CT variants (7.4±1.9 μmol/L and 7.4±1.2 μmol/L) and those with 
the CT variant (19.2±8.1%) had a higher proportion of CD3-/CD56+ pbNK cells than those with the CC and TT variants (17.7±6.6% and 17.9±7. 
0%), but the results of both comparisons were statistically insignificant.
Conclusion: These preliminary results show no difference in plasma homocysteine levels between the RM and control groups or among MTH-
FR genotype variants in the RM group, which may suggest that the plasma homocysteine level is difficult to use as a predictive marker of RM in 
the Korean population. A study of a larger number of patients is needed.
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Introduction
Recurrent miscarriage (RM) has been a challenging topic in repro-
ductive medicine and is observed in 5% of pregnant women. The 
causes of RM are identified in only 50% of patients, and the remain-
ing 50% remain unexplained [1]. Unexplained RM involves immuno-
logic, thrombophilic, and environmental factors. In addition to these 
factors, maternal hyperhomocysteinemia is known as a risk factor for 
RM [2-4].
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Hyperhomocysteinemia is often associated with lowered concen-
trations of B vitamins, especially of folate. Although insufficient sup-
plementation of folate is one of the reasons for hyperhomocystein-
emia, insufficient dietary intake cannot completely explain hyperho-
mocysteinemia because diets usually do not lack vitamins. The ma-
ternal methylenetetrahydrofolate reductase (MTHFR) genotype was 
found to be major genetic determinant of hyperhomocysteinemia 
and some studies have reported an association between the MTHFR 
genotype variant and RM [5-8]. However, the mechanism by which 
homocysteine causes RM remains elusive. Several hypotheses have 
been proposed to explain the role of hyperhomocysteinemia in RM. 
Homocysteine by itself can be embryotoxic [9] or it can potentially 
interact with hemostatic genetic determinants, thereby increasing 
the thrombogenic potential [10,11]. 
Most diseases, such as cardiovascular, autoimmune, and neurode-
generative diseases, are accompanied by hyperhomocysteinemia, 
which is associated with immune system activation.
In these patients, close associations between hyperhomocystein-
emia and the Th1 immune activation, which is reflected by an elevat-
ed serum concentration of immune activation marker, neopterin have 
been reported [12]. Thererfore, a cell-mediated Th1 immune response 
could be involved in hyperhomocysteinemia associated disease.
However, little is known about the role of homocysteine in the im-
munologic condition underlying RM of allogenic graft. Identifying 
the interaction between homocysteine and alloimmunity may allow 
for a better understanding of the mechanism by which hyperhomo-
cysteinemia causes RM.
The current study was undertaken to examine the association be-
tween MTHFR C677T polymorphism and plasma homocysteine con-
centration in RM and to investigate the association between the MTH-
FR genotype variant and alloimmnune activation, especially the pro-
portion of peripheral blood natural killer (pbNK) cells, one of the un-
derlying immunologic determinants of RM.
Methods
1.	Patients
A total of 39 patients with a history of two or more unexplained 
pregnancy losses were recruited to this study. Patients were screened 
for uterine anomaly, parental chromosomal anomalies, anti-phospho-
lipid syndrome (anticardiolipin antibodies and lupus anticoagulant), 
infection (chlamydia trachomatis, ureaplasma), autoimmunity (anti-
thyroglobulin antibodies), and those with positive findings on any of 
the screening tests were excluded from the study. 
A group of 50 fertile couples who had a live birth or were pregnant 
at 24 gestational weeks over without a history of miscarriages were 
enrolled as the control group. 
The institutional review board of Cheil General Hospital and Wom-
en’s Healthcare Center, Kwandong University College of Medicine ap-
proved this study in August, 2008.
2.	Biochemical	measurements
Venous blood was collected in EDTA-containing tubes. Plasma was 
promptly separated by centrifugation at 1,000 rpm for 15 minutes. 
Plasma homocysteine was determined within 1 hour after blood col-
lection by fluorescent polarizing immunoassay in 49 out of 50 fertile 
controls. The reference range was 4.5 to 10.6 μmol/L for homocyste-
ine, 1.1 ng/mL to 20 ng/mL for folate and 214 pg/mL to 914 pg/mL 
for vitamin B12. The intra- and inter-assay coefficients of variation of 
homocysteine were 1.8% and 2.2%, respectively.
The cut-off value for hyperhomocysteinemia was defined as 11.3 
μmol/L, that is, a plasma homocysteine concentration above either 
the 95th percentile of the distribution of the 49 fertile controls. The 
mean homocysteine level was 7.2±1.9 μmol/mL (range, 4.2-13.4 
μmol/mL) and the 95th percentile level was 11.3 μmol/mL in the fer-
tile control group (Figure 1).
3.	MTHFR	genotyping
DNA was extracted from leucocytes with a DNA extraction kit (In-
tron, Seongnam, Korea) according to the manufacturer’s protocol. 
DNA fragments containing the 677th base of MTHFR were amplified 
with a GeneAmp PCR machine (Perkin Elmer 2400, Foster City, CA, 
USA), using a sense primer (5’-TGA AGG AGA AGG TGT CTG CGG GA-
3’) and an antisense primer (5’-AGG ACG GTG CGG TGA GAG TC-3’).
4.	Flow	cytometric	analysis	of	pbNK	cells
Peripheral blood mononuclear cells (PBMC) were isolated from 
Figure	1. Distribution of the plasma homocysteine level in fertile con-
trols (n=49).
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heparinized venous blood samples from the study groups using Fi-
coll-Hypaque (Amersham Biosciences, Piscataway, NJ, USA) density 
centrifugation and washed twice with phosphate-buffered saline 
(PBS). 100 μL of PBMCs was washed in PBS with 1% heat-inactivated 
fetal bovine serum and 0.09% w/v sodium azide (staining buffer) 
twice, followed by staining with the fluorochrome-conjugated mono-
clonal antibodies specific for cell surface antigens. Anti-CD16-FITC/
CE56-PE (mouse monoclonal) (Beckman Coulter, Fullerton, CA, USA) 
was used to detect pNK cells. Appropriate isotype controls were used 
for each antibody. The cell pellets were then fixed and permeabilized 
for 20 minutes using 250 μL of Cytofix/Cytoperm solution (Pharmin-
gen, San Diego, CA, USA). Immunofluorescence and two-color flow 
cytometric analysis were performed using a FACS Calibur flow cy-
tometer (Becton Dickinson, San Jose, CA, USA) with a computer in-
terfacing to BD CellQuestPro for full-list-mode data storage, recovery, 
and analysis. The gate was set on the lymphocyte region by charac-
teristic forward and side scatter parameters. For each sample, 5×106 
PBMCs were evaluated and at least 10,000 cells were analyzed. After 
flow cytometric analysis, 15% of the pNK cell fraction among the 
lymphocytes was defined as the cut-off level for the immunologic 
factor underlying RM. The proportion of CD3-/CD56+ pbNK cells was 
calculated to evaluate the association with the MTHFR genotype and 
homocysteine concentration.
5.	Statistical	analysis
Comparisons of homocysteine and vitamin concentrations between 
individuals were performed using a Student’s t-test and chi-square 
test. One-way analysis of variance was used to assess the differences 
in continuous variables among the different genotypes. The level of 
significance was set at a p-value <0.05. All statistical analyses were 
performed using SPSS ver. 11.5 (SPSS Inc., Chicago IL, USA).
Results
1.	Comparison	between	the	RM	group	and	fertile	controls
The mean plasma homocysteine levels were comparable between 
the RM group and fertile controls; the mean homocysteine level of 
RM was 7.6±1.5 μmol/mL and that of the 49 fertile controls was 7.2± 
1.9 μmol/mL. There was no difference in the incidence of the MTHFR 
C677T genotype variant. The number of normal homozygotes (CC) 
of MTHFR C677T was 14 (35%) in the RM group vs. 17 (33%) in the 
control group; the heterozygous variant (CT), 16 (40%) vs. 26 (53%), 
and the homozygous variant (TT), 9 (25%) vs. 7 (14%), respectively, 
without significant differences. The proportion of individuals with 
hyperhomocysteinemia in the RM group (2.5%) and fertile controls 
(4.0%) was comparable (Table 1).
2.	MTHFR	C677T	variant	and	plasma	homocysteine	levels	in	
the	RM	group
There was a significant negative correlation between folate and ho-
mocysteine level (p=0.007), (data was shown). There was no signifi-
cant difference in the folate or vitamin B12 levels among those with 
each of the MTHFR genotype variants in the RM group. Individuals 
with the TT genotype had higher homocysteine levels than those 
with the CC and CT genotype, but the difference was not significant 
(Table 2). 
3.	MTHFR	C677T	variant	and	proportion	of	CD3-/CD56+	pbNK	
in	the	RM	group
The proportion of CD3-/CD56+ pbNK cells tended to decrease as 
the plasma homocysteine level increased, but the difference was not 
significant (Figure 2). Individuals with the CT genotype had a higher 
proportion of CD3-/CD56+ pbNK cells than those with CC or TT geno-
type, but again, the difference was insignificant. There was no signifi-
cant difference in the homocysteine level above or below the CD3-/
CD56+ pbNK cell threshold value of 15% (Table 3).
Table	1. RM and fertile control group demographics
Fertile control RM  p-value
Patients 50 39 –
Age (yr) 38.5±5.4 34.9±4.4 NS
Gravida 2.8±0.8 0.1±0.5 <0.05
Homocysteine (μmol/L) 7.2±1.9
a 7.6±1.5 NS
No. with hyperhomocysteinemia 2 (4) 1 (2.5) NS
MTHFR C677T variant 33 (66) 25 (64) NS
CC 17 (33) 14 (35) NS
CT 26 (53) 16 (40) NS
TT 7 (14) 9 (25) NS
Values are presented as mean±SD or number (%).
Hyperhomocysteine, [Hcy] >11.3 μmol/L.
RM, recurrent miscarriage; NS, not significant; MTHFR, methylenetetrahydro-
folate reductase.
aMean value of 49 patients out of 50 fertile controls.  
Table	2. Homocysteine level and pbNK cell proportion according to 
the MTHFR variant in the RM group
MTHFR genotype CC (n=14) CT (n=16) TT (n=9) p-value
Incidence (%) 35.9 41.0 23.1 –
Vitamin B12 (pg/mL) 740.4±240.6 724.5±177.4 778.1±237.1 NS
Folate (ng/mL) 13.7±8.2 13.3±6.6 10.1±5.1 NS
Homocysteine (μmol/L) 7.4±1.9 7.4±1.2 7.7±1.1 NS
CD3-/CD56+pbNK cell (%) 17.7±6.6 19.2±8.1 17.9±7.0 NS
Values are presented as mean±SD.
pbNK cell, peripheral blood natural killer cell; MTHFR, methylenetetrahydro-
folate reductase; NS, not significant.www.eCERM.org
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Discussion
Homocysteine is one of the thiols, a group which includes other en-
dogenous thiols, cysteine, and cysteinyglycine, all of which function 
as endogenous antioxidants involved in maintaining the pro-oxidant–
antioxidant balance in human tissues. Homocysteine is formed from 
methionine metabolism and can either be remethylated to methio-
nine or transsulfurized to cystathionine. The remethylation reaction 
depends on 5-methyltetrahydrofolate as the substrate and vitamin 
B12 as the cofactor, and the transsulfuration reaction depends on the 
availability of vitamin B6 as a cofactor. Methyl-tetrahydrofolate is 
formed in a reaction catalyzed by the enzyme MTHFR, the activity of 
which influences the remethylation of homocysteine to methionine. 
Several causes for hyperhomocysteinemia are known. Not only an 
acquired insufficient supply of the B vitamins folic acid and vitamin 
B12, but also inherited defects in homocysteine metabolism, mutation 
C677T in MTHFR play an important role. Mild to moderate hyperho-
mocysteinemia is associated with detrimental effects on reproduc-
tive outcome, ranging from congenital malformations and miscar-
riages to pregnancy-induced hypertension, low birthweight [2,13], 
and elevated homocysteine concentrations are observed in patients 
with cardiovascular [14] and autoimmune as well as neurodegenera-
tive disease [15]. Nelen et al. [4] published a meta-analysis showing a 
significant association between hyperhomocysteinemia and recur-
rent early pregnancy loss (odds ratio [OR], 2.7; 95% confidence inter-
val [CI], 1.4-5.2). However, our study failed to show the difference in 
plasma homocysteine levels between RM and fertile controls, which 
would be due to periconceptional folic acid supplementation to pre-
vent neural tube defects. This is a limitation of our study because we 
did not discriminate between women with and without folic acid 
supplementation because the study was performed retrospectively. 
Because our study failed to show the difference in plasma homoste-
ine levels between the RM and fertile groups, we cannot firmly con-
clude that plasma homocysteine level may not be used as predictive 
marker of RM. A well controlled prospective study is necessary to clar-
ify whether the plasma homosteine level is a causative marker of RM. 
The presence of folate and homocysteine in ovarian follicular fluid 
has previously been demonstrated [16]. Recently, there have been 
reports of the detrimental effect of a high homocysteine concentra-
tion in follicular fluid on embryo quality. Physiological levels of ROS 
in follicular fluid are necessary for oocyte maturation, ovulation, and 
fertilization. Excessive scavenging of ROS by thiols, homocysteine has 
a negative effect on IVF indicating that physiological levels of ROS 
are essential for normal fertilization [17-19]. Therefore, both low and 
high concentrations of homocysteine in follicular fluid are associated 
with reduced embryo quality, suggesting that there must be an opti-
mal level. Although we did not evaluate homocysteine and folic acid 
levels in follicular fluid, there was significant negative correlation be-
tween plasma folate and homocysteine level in RM (p=0.007). We 
can suggest that the deficiency of plasma folate could have a harm-
ful effect on human reproduction by defective homocysteine metab-
olism.
Miscarriage remains the most common complication of pregnancy 
and 2-5% of couples suffer recurrent miscarriage. The cause of miscar-
riage in 50% of women with RM remains unexplained despite thor-
ough investigations. A number of possible etiologies have been pro-
posed to explain the unexplained RM. Immunological factors are in-
volved in the pathogenesis of RM, and maternal hyperhomocystein-
emia is known as a risk factor for recurrent embryo loss [2-4]. 
Maternal adaptation to the immunological responses, specifically 
humoral or cellular immunological responses, to the allogenic em-
bryo is necessary for successful pregnancy. The alterations in cellular 
immunity have been examined and a significant increase in pbNK 
Figure	2. Correlation between plasma homocysteine level and pro-
portion of peripheral blood natural killer cell (pbNK cell). 
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Table	3. Homocysteine level and MTHFR variant incidence according 
to the proportion of pbNK cells in the RM group
<15%
(n=13)
>15%
(n=26) p-value
CD3-/CD56+ pbNK cell (%) 10.6±2.5 22.2±5.4 <0.01
Homocysteine (μmol/L) 7.4±1.5 7.5±1.4 NS
MTHFR C677T mutation  8 (61.5) 17 (65.4) NS
CC  5 (38.5) 9 (34.6) NS
CT  5 (38.5) 11 (42.3) NS
TT  3 (23.1) 6 (23.1) NS
Values are presented as mean±SD or number (%).
MTHFR, methylenetetrahydrofolate reductase; pbNK cell, peripheral blood 
natural killer cell; RM, recurrent miscarriage; NS, not significant.  http://dx.doi.org/10.5653/cerm.2011.38.3.168
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cells is associated with recurrent miscarriage (RM). A mild to moder-
ate increase of pb CD56+ NK cells (12–18%) in 37.3% of women with 
RM and a marked increase (>18%) in 14.7% of women with RM was 
reported [20]. Down-regulation of NK cells in women with RM is as-
sociated with a favorable pregnancy outcome [21]. Emmer et al. [22] 
found that women with RM whose subsequent pregnancy progress-
ed to term delivery had a lower NK cell number than women whose 
subsequent pregnancies miscarried again. Despite the epidemiolog-
ic evidence for a relationship between hyperhomocysteinemia and 
RM, the role of homocysteine in the pathogenesis of the diseases re-
mains to be demonstrated. One of the pathologic mechanisms is 
suggestive of immune system, Th1 immune activation based on stud-
ies in patients with cardiovascular, autoimmune, and neurodegener-
ative disease. In case of coronary artery disease, Th1 immune activa-
tion marker, neopterin concentrations also correlated well with ho-
mocysteine and inversely with folate concentrations (both p<0. 01) 
[23]. A close association was found between increased homocysteine 
and neopterin concentrations in patients with Parkinson’s disease 
[15] and similar findings were also found in patients with rheumatoid 
arthritis [24]. Homocysteine activates the immune system and en-
hances the inflammatory process. Many authors have demonstrated 
that homocysteine has an stimulatory effect on Th1 cytokines, IL-6, 
IL-12, and IL-18, which through activation of intracellular molecules, 
the nuclear factor kB [25,26]. In rheumatoid arthritis, it has been re-
ported that homocysteine enhances cytokine production in synovio-
cytes [27]. However, little is known about the effect of homocysteine 
on immunologic conditions concerning pbNK. Our present study 
show ed a negative correlation between the proportion of CD3-/
CD56+ pbNK cells and homocysteine levels, but the result cannot 
reach a statistically significant power. This is due to the small study 
population of this preliminary study. Therefore, a large-scale study 
would clarify the relationship between pbNK cells and homosteine 
level as an etiologic mechanism of RM which cause inflammatory 
process. Although our study fails to show a statistically significant 
correlation between the proportion of pbNK cells and plasma homo-
cysteine level, it is valuable in that it is the first study to evaluate the 
association between homocysteine level and pbNK cells as one of 
the underlying immunologic determinants of RM. 
Results are still conflicting regarding the association between the 
MTHFR genotype and RM. Nelen et al. [4] reported on a meta-analy-
sis showing a significant association between the MTHFR TT-geno-
type and RM (OR, 1.4; 95% CI, 1.0–2.0). However, another meta-anal-
ysis showed that the MTHFR TT-genotype was not associated with 
RM (OR, 1.21; 95% CI, 1.04–1.40) [28]. In our present study, compar-
ing the incidence of the MTHFR genotype variant between the RM 
group and fertile controls showed no difference and the homocyste-
ine level tended to be higher in the TT genotype, but was not signifi-
cantly different. 
According to our present study, the plasma homocysteine level, hy-
perhomocysteinemia is difficult to use as a predictive marker of RM. 
However, our study is limited in that no discrimination was made be-
tween women with and without folic acid supplementation because 
of its retrospective study design. A study of a larger number of pa-
tients, prospectively designed and controlled, is necessary to clarify 
the association between the MTHFR genotype variant, hyperhomo-
steinemia, folate deficiency, and the proportion of pbNK in patients 
with unexplained RM. 
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